--> Ease of sharing, storing and reading images.
--> Increase in productivity due to the same interface across all imaging modalities.
--> Higher flexibility, since digital images can also be accessed on mobile devices.
--> Rising diagnostic check-ups.
--> High cost of the software, since they are licensed products and not open-source.
--> Dearth of skilled professionals who are trained enough to handle such software.
--> Growing hacking related risks associated with the use of digital storage.
The global imaging analysis software market can be segmented on the basis of:
1. Software Type: Integrated software and standalone software. Due to the growing adoption of imaging systems, the integrated software segment is expected to account for a larger market value.
2. Imaging Type: 2D imaging, 3D imaging, and 4D imaging. While 2D is the traditional imaging type, the 3D and 4D imaging types capture a true three-dimensional image.
3. Imaging modality:Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Magnetic Resonance Imaging (MRI),X-Ray, Computed Tomography (CT), and Ultrasound. These are some of the various types of equipment or probes used for imaging.
4. Application:Cardiology, Orthopedic, Oncology, Neurology, Nephrology, Dental, Gynecology, and Others branches of modern medicine.
5. End User:Hospitals, Clinics, Research and academic institutes, Diagnostic centers, and Ambulatory Surgical Centers.
On the basis of region, the global medical image analysis software market can be segmented into North America, Europe, Asia and Rest of the World.
--> North America: This region is expected to dominate the market in the given forecast period. An aging population, favourable reimbursement policies, and technological advancements are driving this market in North America.
--> Europe: Expected to follow North America in terms of market value as it is doing presently.
--> Asia: The Asian market is expected to experience a higher growth rate in the forecast period especially due to increasing government action towards healthcare infrastructure modernization, ongoing research activities and a growing portfolio of imaging techniques.
--> Koninklijke Philips N.V. (The Netherlands).
--> General Electric Company (U.S.).
--> Siemens AG (Germany).
--> Agfa-Gevaert N.V. (Belgium).
--> Carestream Health, Inc. (U.S.).
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Rest of Eastern Europe
> Asia Pacific
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...